Russell Investments Group Ltd. Purchases 33,704 Shares of CorVel Co. (NASDAQ:CRVL)

Russell Investments Group Ltd. lifted its stake in CorVel Co. (NASDAQ:CRVL - Free Report) by 188.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 51,635 shares of the business services provider's stock after purchasing an additional 33,704 shares during the period. Russell Investments Group Ltd. owned 0.10% of CorVel worth $5,745,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Fifth Third Bancorp boosted its position in CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock valued at $36,000 after acquiring an additional 101 shares in the last quarter. Sanctuary Advisors LLC grew its stake in CorVel by 4.6% in the third quarter. Sanctuary Advisors LLC now owns 2,848 shares of the business services provider's stock worth $931,000 after purchasing an additional 124 shares during the period. Franklin Resources Inc. raised its holdings in CorVel by 9.9% in the third quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider's stock worth $614,000 after purchasing an additional 173 shares in the last quarter. US Bancorp DE lifted its position in CorVel by 225.4% during the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider's stock valued at $43,000 after buying an additional 266 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of CorVel by 175.2% during the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock valued at $48,000 after buying an additional 275 shares in the last quarter. Institutional investors own 51.36% of the company's stock.

Remove Ads

Insider Activity at CorVel

In other news, Director Alan Hoops sold 10,200 shares of the business's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total value of $1,187,178.00. Following the completion of the transaction, the director now owns 118,213 shares in the company, valued at $13,758,811.07. The trade was a 7.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Brandon O'brien sold 1,523 shares of CorVel stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total value of $182,089.88. Following the completion of the sale, the chief financial officer now owns 17,142 shares of the company's stock, valued at $2,049,497.52. The trade was a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,723 shares of company stock valued at $5,757,140. 47.57% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of CorVel from a "hold" rating to a "buy" rating in a research report on Tuesday, April 8th.

CorVel Stock Performance

Shares of CRVL traded up $2.28 during mid-day trading on Tuesday, reaching $118.66. The company had a trading volume of 135,835 shares, compared to its average volume of 113,684. The company has a market capitalization of $6.09 billion, a price-to-earnings ratio of 69.80 and a beta of 0.94. The firm has a 50-day moving average price of $111.36 and a 200 day moving average price of $115.16. CorVel Co. has a 52 week low of $76.20 and a 52 week high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last released its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.